SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Sarepta Therapeutics Maintained Neutral by JP Morgan

JP Morgan maintained its Neutral rating on Sarepta Therapeutics.

SRPT